291 related articles for article (PubMed ID: 30537491)
21. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
Nonaka D; Henley JD; Chiriboga L; Yee H
Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
[TBL] [Abstract][Full Text] [Related]
22. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
23. Cytokeratins in normal thymus and thymic epithelial tumors.
Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
[TBL] [Abstract][Full Text] [Related]
24. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
[TBL] [Abstract][Full Text] [Related]
25. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis?
Jeong YJ; Lee KS; Kim J; Shim YM; Han J; Kwon OJ
AJR Am J Roentgenol; 2004 Aug; 183(2):283-9. PubMed ID: 15269013
[TBL] [Abstract][Full Text] [Related]
26. Prediction of thymoma histology and stage by radiographic criteria.
Yanagawa M; Tomiyama N
Thorac Surg Clin; 2011 Feb; 21(1):1-12, v. PubMed ID: 21070982
[TBL] [Abstract][Full Text] [Related]
27. Chromophobe-like carcinoma of the thymus: A clinicopathological and immunohistochemical correlation of 5 cases.
Weissferdt A; Moran CA
Pathol Res Pract; 2023 Aug; 248():154629. PubMed ID: 37348289
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.
Nakagawa K; Matsuno Y; Kunitoh H; Maeshima A; Asamura H; Tsuchiya R
Chest; 2005 Jul; 128(1):140-4. PubMed ID: 16002927
[TBL] [Abstract][Full Text] [Related]
29. Microthymoma: definition of the entity and distinction from nodular hyperplasia of the thymic epithelium (so-called microscopic thymoma).
Cheuk W; Tsang WY; Chan JK
Am J Surg Pathol; 2005 Mar; 29(3):415-9. PubMed ID: 15725813
[TBL] [Abstract][Full Text] [Related]
30. Thymomas with prominent signet ring cell-like features: a clinicopathologic and immunohistochemical study of 10 cases.
Weissferdt A; Moran CA
Hum Pathol; 2012 Nov; 43(11):1881-6. PubMed ID: 22575262
[TBL] [Abstract][Full Text] [Related]
31. Ectopic hamartomatous thymoma: a clinicopathologic and immunohistochemical analysis of 21 cases with data supporting reclassification as a branchial anlage mixed tumor.
Fetsch JF; Laskin WB; Michal M; Remotti F; Heffner D; Ellis G; Furlong M; Miettinen M
Am J Surg Pathol; 2004 Oct; 28(10):1360-70. PubMed ID: 15371953
[TBL] [Abstract][Full Text] [Related]
32. Cytology of thymomas: emphasis on morphology and correlation with histologic subtypes.
Chhieng DC; Rose D; Ludwig ME; Zakowski MF
Cancer; 2000 Feb; 90(1):24-32. PubMed ID: 10692213
[TBL] [Abstract][Full Text] [Related]
33. Multilocular thymic cyst associated with thymoma: a clinicopathologic study of 20 cases with an emphasis on the pathogenesis of cyst formation.
Nakamura S; Tateyama H; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Mizuno T; Ishiguro F; Yokoi K
Am J Surg Pathol; 2012 Dec; 36(12):1857-64. PubMed ID: 23026930
[TBL] [Abstract][Full Text] [Related]
34. Potentially actionable FGFR2 high-level amplification in thymic sebaceous carcinoma.
Porubsky S; Jessup P; Kee D; Sharma R; Ochi A; Xu H; Froelich JJ; Nott L; Scott C; Awad R; Moldovan C; Hardikar AA; Bohnenberger H; Küffer S; Ströbel P; Marx A
Virchows Arch; 2020 Feb; 476(2):323-327. PubMed ID: 31401665
[TBL] [Abstract][Full Text] [Related]
35. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.
Pfister F; Hussain H; Belharazem D; Busch S; Simon-Keller K; Becker D; Pfister E; Rieker R; Ströbel P; Marx A
Histopathology; 2017 Apr; 70(5):693-703. PubMed ID: 27791295
[TBL] [Abstract][Full Text] [Related]
36. Thymomas With a Prominent Alveolar Growth Pattern: A Clinicopathologic and Immunohistochemical Study of 12 Cases.
Kalhor N; Moran CA
Am J Clin Pathol; 2019 Jan; 151(2):171-175. PubMed ID: 30247496
[TBL] [Abstract][Full Text] [Related]
37. Xanthomatous Thymoma: A Clinicopathologic and Immunohistochemical Study of 10 Cases.
Lindholm KE; Moran CA
Am J Clin Pathol; 2019 May; 151(6):593-597. PubMed ID: 30816919
[TBL] [Abstract][Full Text] [Related]
38. The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.
Li H; Ren B; Yu S; Gao H; Sun PL
BMC Cancer; 2023 Feb; 23(1):161. PubMed ID: 36797681
[TBL] [Abstract][Full Text] [Related]
39. Thymoma with prominent cystic and hemorrhagic changes and areas of necrosis and infarction: a clinicopathologic study of 25 cases.
Moran CA; Suster S
Am J Surg Pathol; 2001 Aug; 25(8):1086-90. PubMed ID: 11474295
[TBL] [Abstract][Full Text] [Related]
40. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
Walts AE; Hiroshima K; Marchevsky AM
Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
